Interestingly, in lower-grade astrocytomas with IDH1 mutations, higher GLUD1 and GPT2 expression correlates with lower GSH levels, potentially increasing sensitivity to oxidative stress and treatments like radiation therapy [137]. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).